Theralase Average Inventory from 2010 to 2026
| TLT Stock | CAD 0.27 0.02 6.90% |
Average Inventory | First Reported 2010-12-31 | Previous Quarter 541.5 K | Current Value 339.2 K | Quarterly Volatility 294.7 K |
Check Theralase Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theralase Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 345.5 K, Interest Expense of 29.1 K or Other Operating Expenses of 4.2 M, as well as many indicators such as Price To Sales Ratio of 67.25, Dividend Yield of 2.16 or PTB Ratio of 37.16. Theralase financial statements analysis is a perfect complement when working with Theralase Technologies Valuation or Volatility modules.
Theralase | Average Inventory |
The evolution of Average Inventory for Theralase Technologies provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Theralase Technologies compares to historical norms and industry peers.
Latest Theralase Technologies' Average Inventory Growth Pattern
Below is the plot of the Average Inventory of Theralase Technologies over the last few years. It is the average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels. Theralase Technologies' Average Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Theralase Technologies' overall financial position and show how it may be relating to other accounts over time.
| Average Inventory | 10 Years Trend |
|
Average Inventory |
| Timeline |
Theralase Average Inventory Regression Statistics
| Arithmetic Mean | 541,506 | |
| Geometric Mean | 440,512 | |
| Coefficient Of Variation | 54.43 | |
| Mean Deviation | 226,140 | |
| Median | 525,860 | |
| Standard Deviation | 294,741 | |
| Sample Variance | 86.9B | |
| Range | 1M | |
| R-Value | 0.28 | |
| Mean Square Error | 85.6B | |
| R-Squared | 0.08 | |
| Significance | 0.28 | |
| Slope | 16,127 | |
| Total Sum of Squares | 1.4T |
Theralase Average Inventory History
About Theralase Technologies Financial Statements
Theralase Technologies investors use historical fundamental indicators, such as Theralase Technologies' Average Inventory, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Theralase Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Average Inventory | 541.5 K | 339.2 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.